4 recruiting, 2 completed, 1 terminated, 1 unknown. 2 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 2 | Recruiting 1, Terminated 1 |
Follow Inflammatory Myositis: new trials by email Literature Review of Inflammatory Myositis trials Research Report on Inflammatory Myositis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinical Study of BCT301 Cell Injection Therapy for Refractory Autoimmune Diseases BCT301 - System Lupus Erythematosus, Systemic Sclerosis (SSc) | Early Phase 1 | Recruiting | Peking University Third Hospital | 10 | 2025-12-11 | 2026-09-23 |
| Rare AutoImmune SElf-management Programme Development Non-interventional study - Systemic Lupus Erthematosus, Systemic Vasculitis | Recruiting | University of the West of England | 360 | 2024-10-01 | 2024-10-15 | |
| ROLE of PLATELETS in the PATHOPHYSIOLOGY of SYSTEMIC LUPUS Systemic Lupus Erythematosus, Systemic Scleroderma Meeting | Recruiting | University Hospital, Strasbourg, France | 450 | 2024-01-09 | 2024-09-19 | |
| Follow-up of Patients With Inflammatory Myopathies Associated With a Biobank Inflammatory Myositis, Idiopathic Inflammatory Myositis | Recruiting | Assistance Publique - Hôpitaux de Paris | 4000 | 2022-10-26 | 2025-04-23 | |
| COVID-19 Vaccination in Rheumatic Disease Patients mRNA COVD19 vaccine - Systemic Lupus Erythematosus, Sjogren's Syndrome | Early Phase 1 | Terminated | Mayo Clinic | 58 | 2021-02-15 | 2022-06-03 |
| Cell Surface Marker Expression in Autoimmune Diseases Systemic Lupus Erythematosus, Sjogren's Syndrome | Completed | Alpine Immune Sciences, Inc. | 14 | 2019-06-12 | 2020-08-27 | |
| Clinical Database and Biobank of Patients With Inflammatory Myopathies: the MASC Project (Myositis, DNA, Serum, Cells) (MASC) Inflammatory Myositis, Idiopathic Inflammatory Myositis | Completed | Groupe Hospitalier Pitie-Salpetriere | 1273 | 2013-12-19 | 2024-05-22 | |
| Rituximab-induced Pulmonary Function Changes Lung function measurement - Rheumatoid Arthritis, Inflammatory Myositis | Unknown | University of Zurich | 80 | 2012-01-01 | 2012-06-29 |
Lupus Erythematosus, Systemic (4) · Sjogren's Syndrome (4) · Scleroderma, Systemic (3) · Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (2) · Arthritis, Rheumatoid (2) · Myositis (2) · Antiphospholipid Syndrome (1) · Arthritis, Psoriatic (1) · Colitis, Ulcerative (1) · Crohn Disease (1) · Disease (1) · Gout (1) · Multiple Sclerosis (1) · Osteoarthritis (1) · Spondylitis, Ankylosing (1)
Musculoskeletal Diseases (8) · Arthritis (6) · Autoimmune Diseases (6) · Connective Tissue Diseases (6) · Immune System Diseases (6) · Joint Diseases (6) · Rheumatic Diseases (6) · Skin and Connective Tissue Diseases (6) · Arthritis, Rheumatoid (4) · Dry Eye Syndromes (4) · Eye Diseases (4) · Lacrimal Apparatus Diseases (4) · Mouth Diseases (4) · Salivary Gland Diseases (4) · Skin Diseases (4)
Transfer Factor (1)
Alpine Immune Sciences, Inc. (1) · Assistance Publique - Hôpitaux de Paris (1) · Groupe Hospitalier Pitie-Salpetriere (1) · Mayo Clinic (1) · Peking University Third Hospital (1) · University Hospital, Strasbourg, France (1) · University of Zurich (1) · University of the West of England (1)
France (3) · Canada (1) · China (1) · Switzerland (1) · United Kingdom (1) · United States (1)
Olivier Benveniste, PU PH (2) · Yves Allenbach (2) · Daniel Franzen, MD (1) · Hu Zeng, PhD (1) · Jan Hillson, MD (1) · Joanna Robson (1)
PMID 16142864, PMID 16987829, PMID 17471524, PMID 20360188, PMID 21109517, PMID 25479696, PMID 34133081, PMID 37010495, PMID 38883792, PMID 39589730, PMID 40569849